Have you seen the pipeline and have any idea re the approval process? We are likely 1-2 months away from getting access to a $1B market as potentially 2nd to market generic and 1-2 months away from access to $160M market as potential first to market generic. These are all in USD terms also. So if we capture 10% market share at 50% discount it's $70M revenue. That is just the beginning... E4 follows that potentially next April. Buying pharma stocks is always about buying future pipeline. If you can't see that, we can't help you.
MYX Price at posting:
35.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)